RxDoctor Payments Data
★ My doctorsLook up a doctor →

Alan Marcus

Endocrinology, Diabetes & Metabolism · Laguna Hills, CANPI 1275631657

Payments from drug & device makers

$145,419in general payments, 2019–2025

Across 1,926 payments — averaging $75.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Corcept Therapeutics$81K
  • Mannkind Corporation$16K
  • Incyte Corporation$15K
  • Vertex$6K
  • AbbVie$4K
  • AstraZeneca$3K
  • plus $21K from 54 others

What the payments were for

  • Consulting fees$42,16736%
  • Speaking & faculty fees$37,95432%
  • Travel & lodging$6,3625%
  • Food & beverage$31,74527%
  • Education$2970%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Corcept Therapeutics96$80,526
Mannkind Corporation122$15,581
Incyte Corporation5$15,061
Vertex2$5,542
AbbVie(2 entities)294$4,399
AstraZeneca(2 entities)119$2,854
Novo Nordisk159$2,528
Amgen(2 entities)132$2,046
Lilly USA, LLC108$1,850
Aimmune Therapeutics, Inc.72$1,491
Nestle Healthcare Nutrition Inc.78$1,274
Dexcom, Inc.54$870
Boehringer Ingelheim48$800
Harmony Biosciences LLC27$703
Takeda Pharmaceuticals U.S.A., Inc.44$679
Johnson & Johnson43$622
Xeris Pharmaceuticals, Inc.33$517
Novartis25$472
Esperion Therapeutics, Inc.23$411
Abbott26$405
Antares Pharma, Inc.37$398
GSK26$383
Vivus LLC18$340
Regeneron Healthcare Solutions, Inc.28$339
Recordati_rare_diseases_inc.15$319
Radius Health, Inc.15$308
Bayer16$305
Jazz Pharmaceuticals Inc.23$304
Pfizer19$241
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC16$240
Axsome Therapeutics, Inc.11$234
Sanofi-aventis U.S. LLC13$218
Insulet Corporation10$213
Ironwood Pharmaceuticals, Inc10$205
Vistapharm, Inc.17$175
Arbor Pharmaceuticals, Inc.10$173
IBSA Pharma Inc.10$168
Endo Pharmaceuticals Inc.8$146
Azurity Pharmaceuticals, Inc.7$134
Merck7$115
EUSA Pharma (US) LLC5$114
BD4$88
Shield Therapeutics Inc5$85
Acella Pharmaceuticals, LLC5$84
Ascensia Diabetes Care US Inc.4$82
Verity Pharmaceuticals Inc.4$80
Averitas Pharma Inc.3$77
Alnylam Pharmaceuticals Inc.4$77
Currax Pharmaceuticals LLC4$69
Amneal Pharmaceuticals LLC4$69
Alfasigma USA, Inc.4$68
Sequel Med Tech, LLC3$68
Amryt Pharma Holdings Ltd4$61
Halozyme Inc4$55
Zyla Life Sciences, Inc.4$54
Cequr Corporation2$46
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)2$42
Eisai Inc.3$41
Gilead2$37
Kyowa Kirin, Inc.2$37

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$145,419 in reported general payments places this provider in the 90th percentile of 952 endocrinology, diabetes & metabolism providers in California.

See all endocrinology, diabetes & metabolism providers in California →

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide621$632,898
MounjaroTirzepatide325$395,564
JardianceEmpagliflozin248$316,812
Repatha SureclickEvolocumab155$143,329
FarxigaDapagliflozin Propanediol106$122,526
Norditropin FlexproSomatropin17$76,117
XyostedTestosterone Enanthate51$59,847
KerendiaFinerenone29$53,423
Praluent PenAlirocumab70$49,902
AfrezzaInsulin Regular, Human47$45,536
EliquisApixaban34$44,956
TrulicityDulaglutide25$35,608
XareltoRivaroxaban40$30,111
SynthroidLevothyroxine Sodium297$30,102
VascepaIcosapent Ethyl32$24,284

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$2,528$632,898621 claims
Lilly USA, LLCMounjaro, Trulicity$1,850$431,173350 claims
Boehringer IngelheimJardiance, Tradjenta$800$327,772262 claims
AstraZenecaFarxiga, Breztri Aerosphere$2,854$135,699125 claims
Antares Pharma, Inc.Xyosted$398$59,84751 claims
BayerKerendia$305$53,42329 claims
AbbVieSynthroid, Linzess$4,399$47,993317 claims
Mannkind CorporationAfrezza$15,581$45,53647 claims
PfizerEliquis$241$44,95634 claims
Johnson & JohnsonXarelto$622$30,11140 claims
Axsome Therapeutics, Inc.Sunosi$234$19,65822 claims
Takeda Pharmaceuticals U.S.A., Inc.Motegrity, Dexilant$679$16,66432 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 952 endocrinology, diabetes & metabolism providers in California.

Other endocrinology, diabetes & metabolism in Laguna Hills

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →